Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 325

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation

Open access
Gueugniaud, Pierre-Yves, David, Jean-Stéphane, Chanzy, Eric, Hubert, Hervé, Dubien, Pierre-Yves, Mauriaucourt, Patrick, Bragança, Coralie, Billères, Xavier, Clotteau-Lambert, Marie-Paule, Fuster, Patrick, Thiercelin, Didier, Debaty, Guillaume, Ricard-Hibon, Agnès, Roux, Patrick, Espesson, Catherine, Querellou, Emgan, Ducros, Laurent, Ecollan, Patrick, Halbout, Laurent, Savary, Dominique, Guillaumée, Frédéric, Maupoint, Régine, Capelle, Philippe, Bracq, Cécile, Dreyfus, Philippe, Nouguier, Philippe, Gache, Antoine, Meurisse, Claude, Boulanger, Bertrand, Lae, Claude, Metzger, Jacques, Raphael, Valérie, Beruben, Arielle, Wenzel, Volker, Guinhouya, Comlavi, Vilhelm, Christian, Marret, Emmanuel · 2008 · New England Journal of Medicine

Abstract

BACKGROUND: During the administration of advanced cardiac life support for resuscitation from cardiac arrest, a combination of vasopressin and epinephrine may be more effective than epinephrine or vasopressin alone, but evidence is insufficient to make clinical recommendations. METHODS: In a multicenter study, we randomly assigned adults with out-of-hospital cardiac arrest to receive successive injections of either 1 mg of epinephrine and 40 IU of vasopressin or 1 mg of epinephrine and saline placebo, followed by administration of the same combination of study drugs if spontaneous circulation was not restored and subsequently by additional epinephrine if needed. The primary end point was survival to hospital admission; the secondary end points were return of spontaneous circulation, survival to hospital discharge, good neurologic recovery, and 1-year survival. RESULTS: A total of 1442 patients were assigned to receive a combination of epinephrine and vasopressin, and 1452 to receive epinephrine alone. The treatment groups had similar baseline characteristics except that there were more men in the group receiving combination therapy than in the group receiving epinephrine alone (P=0.03). There were no significant differences between the combination-therapy and the epinephrine-only groups in survival to hospital admission (20.7% vs. 21.3%; relative risk of death, 1.01; 95% confidence interval [CI], 0.97 to 1.05), return of spontaneous circulation (28.6% vs. 29.5%; relative risk, 1.01; 95% CI, 0.97 to 1.06), survival to hospital discharge (1.7% vs. 2.3%; relative risk, 1.01; 95% CI, 1.00 to 1.02), 1-year survival (1.3% vs. 2.1%; relative risk, 1.01; 95% CI, 1.00 to 1.02), or good neurologic recovery at hospital discharge (37.5% vs. 51.5%; relative risk, 1.29; 95% CI, 0.81 to 2.06). CONCLUSIONS: As compared with epinephrine alone, the combination of vasopressin and epinephrine during advanced cardiac life support for out-of-hospital cardiac arrest does not improve outcome. (ClinicalTrials.gov number, NCT00127907.)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0706873

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 325

Metadata

Authors
Gueugniaud, P.-Y., David, J.-S., Chanzy, E., Hubert, H., Dubien, P.-Y., Mauriaucourt, P., Bragança, C., Billères, X., Clotteau-Lambert, M.-P., Fuster, P., Thiercelin, D., Debaty, G., Ricard-Hibon, A., Roux, P., Espesson, C., Querellou, E., Ducros, L., Ecollan, P., Halbout, L., Savary, D., Guillaumée, F., Maupoint, R., Capelle, P., Bracq, C., Dreyfus, P., Nouguier, P., Gache, A., Meurisse, C., Boulanger, B., Lae, C., Metzger, J., Raphael, V., Beruben, A., Wenzel, V., Guinhouya, C., Vilhelm, C., & Marret, E.
Venue
New England Journal of Medicine
Published
2008-07-03
Volume
359
Issue
1
Pages
21-30
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2020765940
Cited by
325
References
20
FWCI
39.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.